FCM Analysis GR in Steroid-Treatment Patients
Monitoring the GR with a GR-MoAb and FITC-Dex probes by FCM would be useful and convenient in determination GR before the steroid treatment in clinical, especially in steroid resistant states, in order to design more efficient clinical treatment protocols.
|Study Design:||Time Perspective: Prospective|
|Official Title:||Flow Cytometric Analysis of Glucocorticoid Receptor Using Monoclonal Antibody and Fluoresceinated Ligand Probes in Glucocorticoid-Resistant and -Sensitive Patients|
introcellular and exocellular proteins in peripheral blood mononuclear cells of subjects
|Study Start Date:||December 2006|
|Primary Completion Date:||December 2010 (Final data collection date for primary outcome measure)|
In order to assess the efficacy of this method, 100 patients with nephrotic syndrome and systemic lupus erythematosus receiving sufficient prednisolone thereafter and 50 age- and sex-matched normal controls will be studied.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00600652
|Principal Investigator:||Jing Li, professor||Changhai Hospital|